These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9580544)

  • 21. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
    Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
    Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fansidar-associated fatal reaction in an HIV-infected man.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Sep; 37(37):571-2, 577. PubMed ID: 3137443
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
    Jurado R; Garcia-Herola A; Garcia-Lazaro M; Kindelan JM; Villanueva JL; Torre-Cisneros J
    Clin Infect Dis; 1994 Jul; 19(1):218-9. PubMed ID: 7948546
    [No Abstract]   [Full Text] [Related]  

  • 24. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA; Behrens RH; Dunlop J
    Lancet; 1989 Sep; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malaria prevention with Fansidar as a cause of Stevens-Johnson syndrome].
    Claréus BW; Hammar H
    Lakartidningen; 1985 Nov; 82(48):4211. PubMed ID: 4079604
    [No Abstract]   [Full Text] [Related]  

  • 26. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome.
    Fischl MA; Dickinson GM
    Ann Intern Med; 1986 Oct; 105(4):629. PubMed ID: 3489429
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy and prophylaxis of Pneumocystis carinii pneumonia.
    Dutz W; Post C; Jennings-Khodadad E; Fakouhi T; Kohout E; Bandarizadeh B
    Natl Cancer Inst Monogr; 1976 Oct; 43():179-85. PubMed ID: 828241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Reusser P
    Acta Trop; 1980 Sep; 37(3):287-92. PubMed ID: 6106370
    [No Abstract]   [Full Text] [Related]  

  • 29. Fansidar-induced Stevens-Johnson Syndrome.
    Hornstein OP; Ruprecht KW
    N Engl J Med; 1982 Dec; 307(24):1529-30. PubMed ID: 7144829
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.
    Adams SJ; Broadbent J; Clayden LM; Ridley CM
    Postgrad Med J; 1985 Mar; 61(713):263-4. PubMed ID: 3983064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse Reactions in Antifolate-Treated Toxoplasmic Retinochoroiditis.
    Borkowski PK; Brydak-Godowska J; Basiak W; Olszyńska-Krowicka M; Rabczenko D
    Adv Exp Med Biol; 2018; 1108():37-48. PubMed ID: 30191431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome in two children in Ghana following anti-malarial treatment.
    Oduro-Boatey C; Rodrigues O
    Trop Doct; 2005 Apr; 35(2):118-9. PubMed ID: 15970046
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia.
    Lyn PC; Fernandez E
    Med J Aust; 1987 Mar; 146(6):335-6. PubMed ID: 2950306
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Lenox-Smith I
    J Infect; 1987 Jan; 14(1):90-2. PubMed ID: 3819463
    [No Abstract]   [Full Text] [Related]  

  • 36. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
    Teil J; Dupont D; Charpiat B; Corvaisier S; Vial T; Leboucher G; Wallon M; Peyron F
    Pediatr Infect Dis J; 2016 Jun; 35(6):634-8. PubMed ID: 26906163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis and treatment of Pneumocystis carinii pneumonia.
    O'Doherty MJ; Bateman NT
    Br J Hosp Med; 1991 May; 45(5):277-8, 280, 283. PubMed ID: 1676607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.